Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

SCAI recommendations for TAVR access | Cerebral embolic protection | Heart surgery during pregnancy | A new era for Heartflow

News You Need to Know Today
SCAI recommendations for TAVR access | Cerebral embolic protection | Heart surgery during pregnancy | A new era for Heartflow
Wednesday, February 26, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Know your options: What cardiologists recommend when alternative access is required for TAVR

Transfemoral TAVR is not always a viable option. In those instances, the two most effective alternatives are transcarotid access and transcaval access, according to a new SCAI expert consensus statement.

READ MORE >
Newsweek ranked the 50 best heart hospitals in the world
Share on Twitter Share on Facebook Share on Linkedin

Know your options: What cardiologists recommend when alternative access is required for TAVR

Share on Twitter Share on Facebook Share on Linkedin
Newsweek ranked the 50 best heart hospitals in the world
Transfemoral TAVR is not always a viable option. In those instances, the two most effective alternatives are transcarotid access and transcaval access, according to a new SCAI expert consensus statement.
READ MORE >

An updated look at the use of cerebral embolic protection devices during TAVR

Cardiologist Aakriti Gupta, MD, MSc, spoke to Cardiovascular Business about the latest data and trends associated with using cerebral embolic protection devices during TAVR to lower the risk of stroke.

READ MORE >
Aakriti Gupta, MD, Cedars-Sinai, explains use of cerebral embolic protection devices in TAVR
Share on Twitter Share on Facebook Share on Linkedin

An updated look at the use of cerebral embolic protection devices during TAVR

Share on Twitter Share on Facebook Share on Linkedin
Aakriti Gupta, MD, Cedars-Sinai, explains use of cerebral embolic protection devices in TAVR
Cardiologist Aakriti Gupta, MD, MSc, spoke to Cardiovascular Business about the latest data and trends associated with using cerebral embolic protection devices during TAVR to lower the risk of stroke.
READ MORE >

Heart surgery during pregnancy: Tracking the safety of a rare, sometimes unavoidable, scenario

How safe is it to perform cardiac surgery on a pregnant patient? When should care teams try to deliver the baby first and then complete the procedure? A team of Mayo Clinic researchers addressed those very questions, and many others, in a new analysis. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Heart surgery during pregnancy: Tracking the safety of a rare, sometimes unavoidable, scenario

Share on Twitter Share on Facebook Share on Linkedin
How safe is it to perform cardiac surgery on a pregnant patient? When should care teams try to deliver the baby first and then complete the procedure? A team of Mayo Clinic researchers addressed those very questions, and many others, in a new analysis. 
READ MORE >

AI leader Heartflow enters new era focused on delivering personalized care for CAD patients

The company's AI-powered CCTA assessments have already been used to help manage more than 400,000 heart patients around the world.

READ MORE >
Heartflow artificial intelligence CCTA images
Share on Twitter Share on Facebook Share on Linkedin

AI leader Heartflow enters new era focused on delivering personalized care for CAD patients

Share on Twitter Share on Facebook Share on Linkedin
Heartflow artificial intelligence CCTA images
The company's AI-powered CCTA assessments have already been used to help manage more than 400,000 heart patients around the world.
READ MORE >

Featured Articles

Cardiovascular societies support Medicare coverage for renal denervation

CMS is expected to release a proposed national coverage determination decision memo by July.
 

READ MORE >
The Medtronic Symplicity Spyral renal denervation catheter with a simulator model at the ACC 2023 meeting. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

Cardiovascular societies support Medicare coverage for renal denervation

Share on Twitter Share on Facebook Share on Linkedin
The Medtronic Symplicity Spyral renal denervation catheter with a simulator model at the ACC 2023 meeting. Photo by Dave Fornell
CMS is expected to release a proposed national coverage determination decision memo by July. 
READ MORE >

New drug therapies targeting Lp(a) could be a breakthrough in cardiovascular care

Lipoprotein (a) research is on the rise in recent years. Deepak Bhatt, MD, director of Mount Sinai Fuster Heart Hospital, explains why this trend is so important.

READ MORE >
Deepak L. Bhatt, MD, discusses research and drug therapies in development to treat lipoprotein (a). #Lp(a)
Share on Twitter Share on Facebook Share on Linkedin

New drug therapies targeting Lp(a) could be a breakthrough in cardiovascular care

Share on Twitter Share on Facebook Share on Linkedin
Deepak L. Bhatt, MD, discusses research and drug therapies in development to treat lipoprotein (a). #Lp(a)
Lipoprotein (a) research is on the rise in recent years. Deepak Bhatt, MD, director of Mount Sinai Fuster Heart Hospital, explains why this trend is so important.
READ MORE >

Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.

READ MORE >
cardiac amyloidosis on bone scan. Image courtesy of the Department of Nuclear Medicine, Medical University of Vienna, Austria.
Share on Twitter Share on Facebook Share on Linkedin

Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging

Share on Twitter Share on Facebook Share on Linkedin
cardiac amyloidosis on bone scan. Image courtesy of the Department of Nuclear Medicine, Medical University of Vienna, Austria.
After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.
READ MORE >

In Case You Missed It

Treating a broken heart: Beta-blockers improve survival in patients with takotsubo syndrome

Takotsubo syndrome, commonly known as “broken heart syndrome,” is often treated as if it was heart failure, but the optimal clinical approach remains a bit of a mystery.

READ MORE >
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Share on Twitter Share on Facebook Share on Linkedin

Treating a broken heart: Beta-blockers improve survival in patients with takotsubo syndrome

Share on Twitter Share on Facebook Share on Linkedin
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Takotsubo syndrome, commonly known as “broken heart syndrome,” is often treated as if it was heart failure, but the optimal clinical approach remains a bit of a mystery.
READ MORE >

Family of heart patient who died after missing medications in jail settles lawsuit

A 54-year-old heart transplant recipient was unable to take doctor-prescribed medications during his brief stay at a local jail. He died a few days after being released. 

READ MORE >
heart drugs with stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Family of heart patient who died after missing medications in jail settles lawsuit

Share on Twitter Share on Facebook Share on Linkedin
heart drugs with stethoscope
A 54-year-old heart transplant recipient was unable to take doctor-prescribed medications during his brief stay at a local jail. He died a few days after being released. 
READ MORE >

Benzodiazepine use before heart surgery: Should it be embraced or restricted?

Benzodiazepines are administered before a majority of cardiac surgeries to lower the risk of intraoperative awareness. At the same time, however, recent studies have suggested they increase the risk of postoperative delirium.

READ MORE >
heart surgery cardiac surgeons
Share on Twitter Share on Facebook Share on Linkedin

Benzodiazepine use before heart surgery: Should it be embraced or restricted?

Share on Twitter Share on Facebook Share on Linkedin
heart surgery cardiac surgeons
Benzodiazepines are administered before a majority of cardiac surgeries to lower the risk of intraoperative awareness. At the same time, however, recent studies have suggested they increase the risk of postoperative delirium.
READ MORE >

In Other News

VA releases another 1,400 employees as FDA invites 300 back to work

As Elon Musk’s DOGE continues to push for staffing cuts, it appears the FDA may have let too many probationary workers go. 

READ MORE >
DOGE Elon Musk cryptocurrency
Share on Twitter Share on Facebook Share on Linkedin

VA releases another 1,400 employees as FDA invites 300 back to work

Share on Twitter Share on Facebook Share on Linkedin
DOGE Elon Musk cryptocurrency
As Elon Musk’s DOGE continues to push for staffing cuts, it appears the FDA may have let too many probationary workers go. 
READ MORE >

SimonMed Imaging failed to protect patient information before ransomware attack, class action lawsuit claims

Maricopa County, Arizona, resident Rosemary Hamermaster and others are seeking a jury trial and damages of more than $5 million. 

READ MORE >
A cardiology practice in Florida and several of its cardiologists have agreed to pay $2 million to resolve allegations that they violated the False Claims Act and committed fraud. As a part of the agreement, there has been no determination of liability.
Share on Twitter Share on Facebook Share on Linkedin

SimonMed Imaging failed to protect patient information before ransomware attack, class action lawsuit claims

Share on Twitter Share on Facebook Share on Linkedin
A cardiology practice in Florida and several of its cardiologists have agreed to pay $2 million to resolve allegations that they violated the False Claims Act and committed fraud. As a part of the agreement, there has been no determination of liability.
Maricopa County, Arizona, resident Rosemary Hamermaster and others are seeking a jury trial and damages of more than $5 million. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

4 coronavirus considerations | Hypertension-related death skyrockets | Covid-19 unkind to heart patients
What COVID-19 means for cath labs | Mental stress associated with repeat heart attacks | Cannabis & cardiology
Week in Review: Key COVID-19 updates | Stem cell therapy and heart attacks | Risk of death from stroke drops 24%
AHA's role during COVID-19 pandemic | Risk of death from stroke drops 24% | A new warning for heart patients
Electrophysiology & Arrhythmia | March 2020
Structural & Congenital Heart Disease | March 2020
Air pollution and heart failure | Stem cells and cardiac muscle | LVAD and suicide

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …344
    • Page 345
    • Page 346
    • Page 347
    • Page 348
    • Page 349
    • Current page 350
    • Page 351
    • Page 352
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup